Also gassed ....
"The vast majority of small molecule therapeutics are unable to cross the BBB and hence unable to be used as therapeutic interventions for disorders of the central nervous system. As such, there is significant growing interest in using conjugated nanoparticles to cross the BBB and deliver various payloads to the brain to treat a range of pathologies."
This means PAB belongs to an elite club with very few members.
Ann: PAT-DX1-NP crosses BBB and targets tumours, page-9
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.001(14.3%) |
Mkt cap ! $16.46M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.7¢ | $528 | 66.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 4671418 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 960403 | 8 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
0.7¢ |
Change
0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 0.7¢ | 0.7¢ | 0.7¢ | 156250 | ||
| Last updated 10.36am 14/06/2024 ? | |||||
| PAB (ASX) Chart |